SIGN UP
LOG IN
I
IPA
Immunoprecise
0.46
0.00-0.65%Opening13:18 05/02 EDT
OPEN/PREV CLOSE0.4600/0.4624
TODAY RANGE0.4521-0.4879
VOL515.82K
MARKET CAP21.02M
52 WEEK RANGE0.2700-1.390
AVG VOL (3M)1.90M
% TURNOVER1.13%
TURNOVER--
P/E (TTM)-0.4249
% RANGE7.74%
EPS(TTM)-1.0811
P/E(FORWARD)-1.0429
P/B1.216
BVPS0.3779
DIVIDEND--
P/S0.6957
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP19.92M
SHARES OUTSTANDING45.77M
NEXT EARNINGS07/28-08/01
FREE FLOAT43.36M
LOT SIZE1
EX-DIV DATE11/23/2020
News
Press Releases
Financial Reports
Profile
TipRanks·04/11 13:09
ImmunoPrecise Antibodies Aligns with FDA’s Move to Non-Animal Testing
TipRanks·04/10 10:30
ImmunoPrecise Antibodies Partners with RIBOPRO to Enhance Antibody Discovery
Dow Jones·04/01 14:54
ImmunoPrecise Antibodies Price Target Maintained With a $3.00/Share by Benchmark
TipRanks·04/01 00:01
ImmunoPrecise Antibodies Earnings Call Highlights Growth
Dow Jones·03/31 10:53
ImmunoPrecise Antibodies Is Maintained at Buy by HC Wainwright & Co.
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.